Neogen Chemicals Limited carries a market capitalization of 53.14B, placing it among publicly traded companies globally. Its enterprise value stands at 40.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 53.14B |
| Enterprise Value | 40.35B |
Neogen Chemicals Limited currently has 26.38M shares outstanding.
| Shares Outstanding | 26.38M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Neogen Chemicals Limited trades at a trailing price-to-earnings ratio of 102.09. The price-to-sales ratio is 3.40, and the price-to-book ratio stands at 111.11.
| PE Ratio | 102.09 |
| PS Ratio | 3.40 |
| PB Ratio | 111.11 |
| P/TBV Ratio | 3.59 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Neogen Chemicals Limited trades at an EV/EBITDA multiple of 36.76 and an EV/FCF ratio of 76.79. The EV/Sales ratio of 4.68 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 36.76 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.68 |
| EV / EBITDA | 36.76 |
| EV / EBIT | 36.76 |
| EV / FCF | 76.79 |
Neogen Chemicals Limited maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 170.91, indicating elevated leverage, while an interest coverage ratio of 1.46 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.17 |
| Quick Ratio | 0.25 |
| Debt / Equity | 170.91 |
| Debt / EBITDA | 12.71 |
| Interest Coverage | 1.46 |
Neogen Chemicals Limited posts a return on equity of 20.47 and a return on invested capital of 4.26.
| Return on Equity (ROE) | 20.47 |
| Return on Assets (ROA) | 1.24 |
| Return on Invested Capital (ROIC) | 4.26 |
| Return on Capital Employed (ROCE) | 7.15 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.06 |
Over the trailing twelve months, Neogen Chemicals Limited has paid 123.40M in income taxes, reflecting an effective tax rate of 30.06.
| Income Tax | 123.40M |
| Effective Tax Rate | 30.06 |
Neogen Chemicals Limited's stock has gained approximately 24.9325% over the past 52 weeks. The 50-day moving average sits at 1,823.02, while the 200-day moving average is 1,437.99.
| Beta (5Y) | N/A |
| 52-Week Price Change | 24.9325% |
| 50-Day Moving Average | 1,823.02 |
| 200-Day Moving Average | 1,437.99 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Neogen Chemicals Limited generated 8.62B in revenue and converted that into 287.10M in net income, yielding earnings per share of 10.89. EBITDA reached 1.10B, while operating income came in at 1.10B.
| Revenue | 8.62B |
| Gross Profit | 3.96B |
| Operating Income | 1.10B |
| Pretax Income | 410.50M |
| Net Income | 287.10M |
| EBITDA | 1.10B |
| EBIT | 1.10B |
| Earnings Per Share (EPS) | 10.89 |
Neogen Chemicals Limited holds 2.91B in cash and equivalents against 13.95B in total debt, resulting in a net debt position of 13.25B. Total book value stands at 263.80M, with working capital of 2.05B providing operational flexibility.
| Cash & Cash Equivalents | 2.91B |
| Total Debt | 13.95B |
| Net Debt | 13.25B |
| Equity (Book Value) | 263.80M |
| Book Value Per Share | 10.01 |
| Working Capital | 2.05B |
Neogen Chemicals Limited operates with a gross margin of 45.88, reflecting its pricing power and cost economics. The operating margin of 12.73 and net profit margin of 3.33 provide insight into operational efficiency.
| Gross Margin | 45.88 |
| Operating Margin | 12.73 |
| Pretax Margin | 4.76 |
| Profit Margin | 3.33 |
| EBITDA Margin | 12.73 |
Neogen Chemicals Limited posts an Altman Z-Score of 1.35, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.35 |